Related Experiment Videos
Methodological approaches to ADR detection in out-patient children
1Department of Pharmacology and Physical Medicine, University of La Laguna Tenerife, Spain.
Bratislavske Lekarske Listy
|December 1, 1991
Summary
Children frequently receive medications, necessitating a careful balance between drug benefits and risks. This study reviews methods for detecting adverse drug reactions (ADRs) and drug-related problems (DRPs) in pediatric populations.
Area of Science:
- Pediatric pharmacology
- Drug safety and pharmacovigilance
- Clinical risk management
Background:
- Medications are widely used across all age groups, with children often receiving drugs after medical consultations.
- Drugs, while therapeutic, are chemicals with the potential to cause harm, requiring a risk-benefit analysis by physicians.
- Harm from drugs can manifest as Adverse Drug Reactions (ADRs) or Drug-Related Problems (DRPs).
Purpose of the Study:
- To discuss methods for detecting and controlling adverse drug effects in children.
- To highlight the importance of monitoring for both classical ADRs and broader DRPs.
- To review key systems for pharmacovigilance in pediatric populations.
Main Methods:
- Discussion of the Spontaneous Reporting System for ADRs.
- Explanation of Record Linkage in Computerized Databases.
- Overview of Prescription-Event Monitoring, Sample Monitoring, and Therapeutic Audits.
Main Results:
- The incidence of ADRs in outpatient children is low, ranging from 0.7% to 4%.
- Various pharmacovigilance systems are available for detecting and controlling adverse drug events.
- Effective monitoring is crucial for identifying serious and unexpected ADRs.
Conclusions:
- Robust systems are essential for monitoring drug safety in children.
- Understanding and mitigating both ADRs and DRPs is critical for pediatric patient well-being.
- Continuous evaluation of drug effects ensures safer medication practices for children.